In addition to HCC, the promotion of EMT by UBAP2L has also been reported in prostate, lung and gastric cancers (Li and Huang, 2014; Aucagne et al., 2017; Lin et al., 2021). This evidence concerns the gene UBAP2L and hepatocellular carcinoma.